Distinctions in the molecular determinants of charged and neutral dihydropyridine block of L-type calcium channels

Journal of Pharmacology and Experimental Therapeutics

Volumn 289, Issue 3, 1999, Pages 1472-1479

  Lacinova L ^a,b,d   An, R H ^a   Xia, J ^a   Ito, H ^a,b   Klugbauer, N ^a,b   Triggle, D ^a,c   Hofmann, F ^a,b   Kass, R S ^a  

^a Columbia University ^*  (United States)

^b TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^c UNIVERSITY AT BUFFALO   (United States)

^d INSTITUTE OF MOLECULAR PHYSIOLOGY AND GENETICS   (Slovakia)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM; CALCIUM CHANNEL; DIHYDROPYRIDINE; ISRADIPINE; VERAPAMIL;

ANIMAL CELL; ARTICLE; CHANNEL GATING; DRUG BINDING SITE; DRUG RECEPTOR BINDING; DRUG SENSITIVITY; DRUG STRUCTURE; MEMBRANE POTENTIAL; MOLECULAR INTERACTION; NONHUMAN; PRIORITY JOURNAL;

AMINO ACID SEQUENCE; AMINO ACID SUBSTITUTION; CALCIUM CHANNEL BLOCKERS; CALCIUM CHANNELS; CALCIUM CHANNELS, L-TYPE; CELL LINE; CELL MEMBRANE; DIHYDROPYRIDINES; HUMANS; ISRADIPINE; KINETICS; MEMBRANE POTENTIALS; MODELS, MOLECULAR; MUTAGENESIS, SITE-DIRECTED; PATCH-CLAMP TECHNIQUES; PROTEIN STRUCTURE, SECONDARY; RECOMBINANT FUSION PROTEINS; RECOMBINANT PROTEINS; THREONINE; TRANSFECTION; TYROSINE; VERAPAMIL;

EID: 0032994149     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (37)

1. Baindur N, Rutledge A and Triggle DJ (1993) A homologous series of permanently charged 1,4-dihydropyridines: Novel probes designed to localize drug binding sites on ion channels. J Med Chem 36:3743-3745.
2. Bangalore R, Baindur N, Rutledge A, Triggle DJ and Kass RS (1994) L-type calcium channels-asymmetrical intramembrane binding domain revealed by variable length, permanently charged 1,4-dihydropyridines. Mol Pharmacol 46:660-666.
3. 2/d subunit on ionic and gating current in transiently-transfected HEK 293 cells. Am J Physiol 270:H1521-H1528.
4. Bean BP (1984) Nitrendipine block of cardiac calcium channels: High-affinity binding to the inactivated state. Proc Natl Acad Sci USA 81:6388-6392.
5. Biel M, Ruth P, Bosse E, Hullin R, Stuhmer W, Flockerzi V and Hofmann F (1990) Primary structure and functional expression of a high voltage activated calcium channel from rabbit lung. FEBS Lett 269:409-412.
6. 2+ channels. Critical involvement of tyrosine residues in motif IIIS6 and IVS6. J Biol Chem 272:24952-24960.
7. Catterall WA (1996) Molecular properties of sodium and calcium channels. (Review; 63 refs) J Bioenerg Biomembr 28:219-230.
8. Ehara T and Kaufmann R (1978) The voltage- and time-dependent effects of (-)-verapamil on the slow inward current in isolated cat ventricular myocardium. J Pharmacol Ezp Ther 207:49-55.
9. Grabner M, Wang Z, Hering S, Striessnig J and Glossmann H (1996) Transfer of 1,4-dihydropyridine sensitivity from L-type to class A (BI) calcium channels. Neuron 16:207-218.
10. He M, Bodi I, Mikala G and Schwartz A (1997) Motif Iii S5 of L-type calcium channels is involved in the dihydropyridine binding site - a combined radioligand binding and electrophysiological study. J Biol Chem 272:2629-2633.
11. Hille B (1977) Local anesthetics: Hydrophilic and hydrophobic pathways for the drug-receptor reaction. J Gen Physiol 69:497-515.
12. Hockerman GH, Johnson BD, Abbott MR, Scheuer T and Catterall WA (1997a) Molecular determinants of high affinity phenylalkylamine block of L-type calcium channels in transmembrane segment Iiis6 and the pore region of the alpha(1) subunit. J Biol Chem 272:18759-18765.
13. Hockerman GH, Peterson BZ, Johnson BD and Catterall WA (1997b) Molecular determinants of drug binding and action on L-type calcium channels. Annu Rev Pharmacol Toxicol 37:361-396.
14. 2+ channel diversity. Annu Rev Neurosci 17:399-418.
15. Hondeghem LM and Katzung BG (1977) Time- and voltage-dependent interactions of antiarrhythmic drugs with cardiac sodium channels. (Review) Biochim Biophys Acta 472:373-398.
16. Ito H, Klugbauer N and Hofmann F (1997) Transfer of the high-affinity dihydroyridine sensitivity from L-type to non-L-type calcium channels. Mol Pharmacol 52:735-740.
17. Kass RS (1982) Nisoldipine: A new, more selective calcium current blocker in cardiac Purkinje fibers. J Pharmacol Exp Ther 223:446-456.
18. Lee KS and Tsien RW (1983) Mechanism of calcium channel blockade by verapamil, D600, diltiazem and nitrendipine in single dialyzed heart cells. Nature (Lond) 302:790-794.
19. Mikami A, Imoto K, Tanabe T, Niidome T, Mori Y, Takeshima H, Narumiya S and Numa S (1989) Primary structure and functional expression of the cardiac dihydropyridine-sensitive calcium channel. Nature (Lond) 340:230-233.
20. 2+ channel alpha(1) subunit. Biochemistry 34:9350-9355.
21. Mitterdorfer J, Wang Z, Sinnegger MJ, Hering S, Striessnig J, Grabner M and Glossmann H (1996) Two amino acid residues in the IIIS5 segment of L-type calcium channels differentially contribute to 1,4-dihydropyridine sensitivity. J Biol Chem 271:30330-30335.
22. Nawrath H and Wegener JW (1997) Kinetics and state-dependent effects of verapamil on cardiac L-type calcium channels. Naunyn-Schmiedeberg's Arch Pharmacol 355:79-86.
23. Peterson BZ and Catterall WA (1995) Calcium binding in the pore of L-type calcium channels modulates high affinity dihydropyridine binding. J Biol Chem 270: 18201-18204.
24. Peterson BZ, Johnson BD, Hockerman GH, Acheson M, Scheuer T and Catterall WA (1997) Analysis of the dihydropyridine receptor site of L-type calcium channels by alanine-scanning mutagenesis. J Biol Chem 272:18752-18758.
25. Peterson BZ, Tanada TN and Catterall WA (1996) Molecular determinants of high affinity dihydropyridine binding in L-type calcium channels. J Biol Chem 271: 5293-5296.
26. Regulla S, Schneider T, Nastainczyk W, Meer HW and Hofmann F (1991) Identification of the site of interaction of the dihydropyridine channel blockers nitrendipine and azidopine with the calcium-channel a1 subunit. EMBO J 10:45-49.
27. Sanguinetti MC and Kass RS (1984) Voltage-dependent block of calcium channel current in the calf cardiac Purkinje fiber by dihydropyridine calcium channel antagonists. Circ Res 55:336-348.
28. Sather WA, Yang J and Tsien RW (1994) Structural basis of ion channel permeation and selectivity. Curr Opin Neurobiol 4:313-323.
29. 2+ channel alpha 1 subunit. Receptors Channels 2:255-270.
30. Schuster A, Lacinova L, Klugbauer N, Ito H, Birnbaumer L and Hormann F (1996) The IVS6 segment of the L-type calcium channel is critical for the actin of dihydropyridines and phenylalkylamines. EMBO J 15:2365-2370.
31. 2+ channel splice variants. J Biol Chem 270: 10540-10543.
32. 3H-azidopine within the alpha1 subunit. Proc Natl Acad Sci USA 88:10769-10773.
33. Tang S, Yatani A, Bahinski A, Mori Y and Schwartz A (1993) Molecular localization of regions in the L-type calcium channel critical for dihydropyridine action. Neuron 11:1013-1021.
34. 2+ channel function and drug action. Trends Pharmacol Sci 16:43-49.
35. Welling A, Kwan YW, Bosse E, Flockerzi V, Hofmann F and Kass RS (1993) Subunit-dependent modulation of recombinant L-type calcium channels: Molecular basis for dihydropyridine tissue selectivity. Circ Res 73:974-980.
36. 2+ channels. Circ Res 81:526-532.
37. 2+ channel sensitivity towards the blocker isradipine is affected by alternative splicing of the human alpha1C subunit gene. FEBS Lett 427:220-224.